Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA3 | P07451 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA6 | P23280 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12317015 | 0.95 | ODC1 (0.39) | ODC1CYP3A4NFKB1 | |
| SCHEMBL16807587 | 0.92 | NFKB1 (0.39) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL19655569 | 0.88 | CYP3A4 (0.46) | ODC1CYP3A4DNM1TSHR | |
| Ammonia Solution, Strong SCHEMBL14860334 | 0.86 | CYP3A4 (0.40) | ODC1CYP3A4DNM1TSHR | |
| SCHEMBL6885240 | 0.85 | THRB (0.40) | ODC1CYP3A4DNM1TSHR | |
| SCHEMBL12201021 | 0.85 | CYP3A4 (0.38) | ODC1CYP3A4DNM1TSHR | |
| SCHEMBL15146724 | 0.85 | ODC1 (0.36) | ODC1CYP3A4 | |
| SCHEMBL11965457 | 0.81 | — | — | |
| SCHEMBL13574313 | 0.81 | — | — | |
| SCHEMBL15697257 | 0.81 | LMNA (0.46) | ODC1NFKB1LMNATSHRBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366490-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN INC (US) | 2024-11-07 | — | — | US | claimed |
| US-20220370323-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN, INC. | 2022-11-24 | — | — | US | claimed |
| US-20200352843-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN, INC. | 2020-11-12 | — | — | US | claimed |
| US-10758470-B2 | Cross linked silk-hyaluronic acid composition | ALLERGAN, INC. (US) | 2020-09-01 | — | — | US | claimed |
| EP-2988791-B1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN INC (US) | 2019-06-12 | — | — | EP | claimed |
| US-10154951-B2 | Cross linked silk-hyaluronic acid composition | ALLERGAN, INC. (US) | 2018-12-18 | — | — | US | claimed |
| US-20180303742-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN, INC. | 2018-10-25 | — | — | US | claimed |
| US-20160361247-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN, INC. | 2016-12-15 | — | — | US | claimed |
| EP-2988791-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN, INC. (US) | 2016-03-02 | — | — | EP | claimed |
| WO-2014176158-A1 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | ALLERGAN, INC. (US) | 2014-10-30 | — | — | WO | claimed |
| US-20140315828-A1 | CROSS-LINKED SILK-HYALURONIC ACID COMPOSITIONS | ALLERGAN, INC. (US) | 2014-10-23 | — | — | US | claimed |
| EP-2787959-A2 | DERMAL FILLER COMPOSITIONS | ALLERGAN, INC. (US) | 2014-10-15 | — | — | EP | claimed |
| WO-2013086024-A2 | DERMAL FILLER COMPOSITIONS | ALLERGAN, INC. (US) | 2013-06-13 | — | — | WO | claimed |
| US-20130096081-A1 | DERMAL FILLER COMPOSITIONS | ALLERGAN, INC. (US) | 2013-04-18 | — | — | US | claimed |
| US-20250340675-A1 | NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS | WiQo S.P.A. (IT) | 2025-11-06 | — | — | US | disclosed |
| US-12458582-B2 | Stabilized hyaluronic acid | CROMA-PHARMA GMBH (AT) | 2025-11-04 | — | — | US | disclosed |
| EP-4578462-A2 | DERMAL FILLER COMPOSITIONS | ALLERGAN Industrie, SAS (FR) | 2025-07-02 | — | — | EP | disclosed |
| WO-2000076760-A1 | POLYMERIC MEMBRANES FUNCTIONALIZED WITH POLYHYDROXYPYRIDINONE LIGANDS | IBC ADVANCED TECHNOLOGIES, INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000076616-A1 | PARTICULATE SOLID SUPPORTS FUNCTIONALIZED WITH POLYHYDROXYPYRIDINONE LIGANDS | IBC ADVANCED TECHNOLOGIES, INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| US-4383107-A | POLYTRIAZINES; CURABLE; CASTINGS; ADHESIVES; FOAMS | CIBA-GEIGY CORPORATION (US) | 1983-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458582-B2 | Stabilized hyaluronic acid | CD44, HSPH1, ACR | ODC1 4466/4885CYP3A4 4267/4885NFKB1 3685/4885 |
| US-20250340675-A1 | NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS | CD44, MMP1, HAAO | ODC1 3633/4885CYP3A4 1019/4885NFKB1 2307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.